Form 8-K - Current report:
SEC Accession No. 0001213900-26-054019
Filing Date
2026-05-08
Accepted
2026-05-08 17:20:21
Documents
36
Period of Report
2026-05-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0289893-8k_allarity.htm   iXBRL 8-K 25118
2 COMPANY PRESENTATION ea028989301ex99-1.htm EX-99.1 30041
3 PRESS RELEASE, DATED MAY 8, 2026 ea028989301ex99-2.htm EX-99.2 16016
4 GRAPHIC ea028989301_ex99-1img1.jpg GRAPHIC 446596
5 GRAPHIC ea028989301_ex99-1img2.jpg GRAPHIC 935197
6 GRAPHIC ea028989301_ex99-1img3.jpg GRAPHIC 449025
7 GRAPHIC ea028989301_ex99-1img4.jpg GRAPHIC 353191
8 GRAPHIC ea028989301_ex99-1img5.jpg GRAPHIC 347688
9 GRAPHIC ea028989301_ex99-1img6.jpg GRAPHIC 262460
10 GRAPHIC ea028989301_ex99-1img7.jpg GRAPHIC 300224
11 GRAPHIC ea028989301_ex99-1img8.jpg GRAPHIC 292471
12 GRAPHIC ea028989301_ex99-1img9.jpg GRAPHIC 365253
13 GRAPHIC ea028989301_ex99-1img10.jpg GRAPHIC 416034
14 GRAPHIC ea028989301_ex99-1img11.jpg GRAPHIC 130778
15 GRAPHIC ea028989301_ex99-1img12.jpg GRAPHIC 330768
16 GRAPHIC ea028989301_ex99-1img13.jpg GRAPHIC 150007
17 GRAPHIC ea028989301_ex99-1img14.jpg GRAPHIC 186999
18 GRAPHIC ea028989301_ex99-1img15.jpg GRAPHIC 291074
19 GRAPHIC ea028989301_ex99-1img16.jpg GRAPHIC 291374
20 GRAPHIC ea028989301_ex99-1img17.jpg GRAPHIC 257753
21 GRAPHIC ea028989301_ex99-1img18.jpg GRAPHIC 334113
22 GRAPHIC ea028989301_ex99-1img19.jpg GRAPHIC 358750
23 GRAPHIC ea028989301_ex99-1img20.jpg GRAPHIC 300330
24 GRAPHIC ea028989301_ex99-1img21.jpg GRAPHIC 521480
25 GRAPHIC ea028989301_ex99-1img22.jpg GRAPHIC 453868
26 GRAPHIC ea028989301_ex99-2img1.jpg GRAPHIC 5699
  Complete submission text file 0001213900-26-054019.txt   10855427

Data Files

Seq Description Document Type Size
27 XBRL SCHEMA FILE allr-20260508.xsd EX-101.SCH 3014
28 XBRL LABEL FILE allr-20260508_lab.xml EX-101.LAB 34239
29 XBRL PRESENTATION FILE allr-20260508_pre.xml EX-101.PRE 22358
39 EXTRACTED XBRL INSTANCE DOCUMENT ea0289893-8k_allarity_htm.xml XML 3213
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 26959914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)